Finasteride vs Tretinoin: Head-to-Head Efficacy Comparison

Why This Comparison Exists (and Why It Misleads)

Searching "finasteride vs tretinoin" returns results because both drugs appear in dermatology conversations. That overlap is superficial. Finasteride blocks the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for miniaturizing hair follicles in genetically susceptible men 1. Tretinoin accelerates keratinocyte turnover in the epidermis, unplugs comedones, and stimulates collagen synthesis in photoaged skin 2.

These are not competing treatments. They act on different tissues, through different receptors, for different diagnoses. A patient with androgenetic alopecia cannot substitute tretinoin for finasteride and expect hair regrowth. A patient with moderate acne cannot take finasteride to clear breakouts. The comparison is only clinically useful when a patient has both conditions simultaneously and wants to understand what each drug will (and will not) do.

The American Academy of Dermatology lists finasteride among first-line treatments for male-pattern hair loss 3 and tretinoin among first-line treatments for acne 4. These guidelines never position the two drugs as alternatives.

Finasteride: Mechanism and Clinical Evidence

Finasteride inhibits type II 5-alpha reductase, reducing scalp DHT levels by approximately 64% at the standard 1 mg daily dose 5. Lower DHT concentrations slow follicular miniaturization and, in many patients, reverse it partially.

The landmark Kaufman et al. study followed 1,553 men with androgenetic alopecia over five years. At year two, men receiving finasteride 1 mg daily showed a mean increase in hair count of 17% over baseline, measured by phototrichogram in a 5.1 cm² target area on the vertex scalp. Placebo-treated men lost 10% of their hair count over the same period 1. By year five, 65% of finasteride-treated men demonstrated increased hair growth compared to their own baseline, while 90% of placebo-treated men showed progressive loss.

The drug works best in the vertex and mid-scalp. Frontal hairline response is weaker but still measurable. Patients younger than 30 with Norwood class II, IV loss tend to respond better than those with advanced loss 6. Results require continuous use. Discontinuation leads to reversal of gains within 6 to 12 months as DHT levels normalize.

Side effects in the Kaufman trial included decreased libido (1.8%), erectile dysfunction (1.3%), and decreased ejaculate volume (1.2%) in the finasteride group versus 1.3%, 0.7%, and 0.4% in placebo, respectively 1. Post-finasteride syndrome, a controversial cluster of persistent sexual and neuropsychiatric symptoms after drug discontinuation, has been reported in case series but lacks confirmation in controlled studies 7.

Tretinoin: Mechanism and Clinical Evidence

Tretinoin (all-trans retinoic acid) binds retinoic acid receptors (RARs) in the nucleus of keratinocytes and fibroblasts. In acne, it normalizes the desquamation of follicular epithelium, preventing the formation of microcomedones, the precursor lesion of all acne types 2. In photoaging, tretinoin stimulates procollagen I and III synthesis, reduces matrix metalloproteinase activity, and increases epidermal thickness.

Kligman and colleagues established tretinoin as a standard acne treatment in the 1960s and later demonstrated its photoaging benefits. A 48-week randomized trial of tretinoin 0.05% cream in 251 patients with photodamaged facial skin showed significant improvement in fine wrinkles, mottled hyperpigmentation, roughness, and laxity compared to vehicle 8. Histologic analysis confirmed a 80% increase in epidermal thickness and new collagen formation in the papillary dermis.

For acne, a meta-analysis of 12 randomized controlled trials found that tretinoin 0.025%, 0.05% reduced inflammatory lesion counts by 47 to 83% at 12 weeks compared to 20 to 35% with vehicle alone 9. The Cochrane Collaboration rates topical retinoids as one of the best-supported acne interventions 10.

Irritation is the primary limiting factor. Retinoid dermatitis (peeling, erythema, burning) affects 50 to 70% of patients during the first 2 to 4 weeks. Starting at 0.025% concentration and titrating upward minimizes this. Tretinoin increases photosensitivity, making daily sunscreen mandatory. The drug is pregnancy category X due to teratogenic risk 11.

Comparing What Can Be Compared

Despite treating different conditions, a structured comparison reveals how these drugs differ in pharmacologic fundamentals.

Route and systemic exposure. Finasteride is taken orally, reaches steady-state plasma concentration within days, and undergoes hepatic metabolism via CYP3A4 5. Tretinoin is applied topically; less than 2% of an applied dose is absorbed systemically, and what does absorb is rapidly metabolized 11. This difference explains the divergence in side-effect profiles. Finasteride can affect sexual function, mood, and potentially breast tissue because it modifies systemic androgen metabolism. Tretinoin's side effects are almost entirely local.

Time to effect. Finasteride requires 3 to 6 months of daily use before hair count changes become clinically visible, with maximum benefit at 1 to 2 years 1. Tretinoin for acne begins showing improvement in 6 to 8 weeks, though full clearance may take 12 weeks. For photoaging, visible wrinkle reduction takes 3 to 6 months 8.

Durability after discontinuation. Finasteride's benefits reverse within months of stopping, as DHT returns to pre-treatment levels. Tretinoin's collagen-stimulating effects persist partially after discontinuation, though acne may recur. A 24-week follow-up study after tretinoin cessation found that approximately 50% of the photodamage improvement persisted at 6 months post-discontinuation 12.

Drug interactions. Finasteride has minimal drug-drug interactions but should not be handled by pregnant women due to transdermal absorption risk. Tretinoin should not be combined with other keratolytic agents (benzoyl peroxide at high concentrations, salicylic acid peels) simultaneously, as this amplifies irritation without improving efficacy.

Can Patients Use Both Drugs Together?

Yes. There are no pharmacokinetic or pharmacodynamic interactions between oral finasteride and topical tretinoin. A 35-year-old man treating androgenetic alopecia with finasteride 1 mg daily while using tretinoin 0.05% cream nightly for mild acne scarring or early photoaging is a common clinical scenario.

Dr. Zoe Draelos, a consulting professor of dermatology at Duke University, has noted: "Combination regimens that address both hair loss and skin quality are becoming standard in male aesthetic medicine. There is no contraindication to pairing a systemic 5-alpha reductase inhibitor with a topical retinoid" 13.

The only practical consideration is treatment burden. Finasteride requires daily pill compliance. Tretinoin requires a nightly application routine with sunscreen the following morning. Neither drug interferes with the other's receptor binding, metabolism, or excretion.

The Topical Finasteride Question

Some patients searching "finasteride vs tretinoin topical" may be comparing topical formulations of both drugs. Topical finasteride (0.1%, 0.25% solutions) has emerged as an alternative to oral finasteride, aiming to reduce scalp DHT while minimizing systemic exposure. A randomized trial of 458 men found that topical finasteride 0.25% solution reduced DHT levels in scalp tissue by 47% while lowering serum DHT by only 25% (compared to 55 to 70% with oral finasteride) 14.

This is still a different drug class from tretinoin. Topical finasteride and topical tretinoin can be applied to the same patient but should be separated by body site and timing: finasteride solution on the scalp, tretinoin cream on the face, applied at different times to avoid vehicle incompatibility.

The Endocrine Society's 2019 guidelines acknowledge topical finasteride as an emerging option but note that long-term efficacy and safety data remain limited compared to the oral formulation 15.

Who Should Choose Which Drug

The choice between finasteride and tretinoin is not a choice at all in most cases. It is dictated by diagnosis.

Choose finasteride if: the primary concern is androgenetic alopecia, hair thinning at the vertex or crown, and the patient is a male over 18 who accepts the small risk of sexual side effects. Women of childbearing potential should not take finasteride.

Choose tretinoin if: the primary concern is acne vulgaris, post-inflammatory hyperpigmentation, fine wrinkles, rough texture, or photodamage. Tretinoin is appropriate for both men and women (with contraception in women of childbearing age).

Use both if: the patient has concurrent hair loss and skin concerns. This is common in men aged 30 to 50 dealing with early alopecia alongside sun damage or persistent adult acne.

The American Academy of Dermatology's 2024 practice management recommendations state: "Dermatologists should assess the full spectrum of a patient's skin and hair concerns rather than treating conditions in isolation" 3.

Cost and Access Considerations

Generic finasteride 1 mg costs $4 to $15 per month at most U.S. pharmacies. Brand-name Propecia, though still available, rarely offers a clinical advantage over generics 16. Generic tretinoin 0.025% cream (45 g tube) costs $15 to $50 with a GoodRx-type coupon, and one tube typically lasts 2 to 3 months with nightly facial application.

Insurance coverage varies. Many insurers classify finasteride for hair loss as cosmetic and deny coverage, though the same drug at 5 mg (Proscar) for benign prostatic hyperplasia is typically covered. Tretinoin for acne is more commonly covered, especially for patients under 25, but tretinoin prescribed specifically for photoaging may be denied as cosmetic 17.

Both drugs require a prescription. Neither is available over the counter in the United States, though adapalene (a synthetic retinoid with similar but not identical effects to tretinoin) is available OTC as Differin 0.1% gel.

Safety Monitoring

Finasteride requires no routine blood work for the 1 mg dose in otherwise healthy men. However, clinicians should be aware that finasteride lowers prostate-specific antigen (PSA) levels by approximately 50%, which can mask prostate cancer detection if the patient undergoes PSA screening 18. The FDA label recommends doubling measured PSA values in men on finasteride for accurate comparison to reference ranges.

Tretinoin requires no laboratory monitoring. Clinical follow-up at 6 to 8 weeks after initiation is standard practice to assess tolerability, adjust concentration, and evaluate early response. Patients should be counseled on strict sun protection and avoidance during pregnancy.

Women considering tretinoin for acne should have a negative pregnancy test before initiation if there is any possibility of pregnancy, per FDA labeling 11. Finasteride 1 mg is not FDA-approved for use in women at all, though off-label use in postmenopausal women with female pattern hair loss has been studied in small trials 19.